Skip to main content
. Author manuscript; available in PMC: 2021 Sep 28.
Published in final edited form as: Cancer Immunol Res. 2020 Jan 17;8(3):345–355. doi: 10.1158/2326-6066.CIR-19-0517

Figure 2. CD44 expression within MC38-luc, LL/2, and MOC1 tumors.

Figure 2.

A-C.Immunohistochemistry staining was performed to examine CD44 expression as a target for NIR-PIT within (A) MC38-luc, (B) LL/2, and (C) MOC1 tumors without treatment. Representative images from at least three samples are shown (×200).